Comparing the current results to its competitors, Sotera Health reported Revenue increase in the 2 quarter 2026 by 9.45 % year on year. The sales growth was above Sotera Health's competitors' average revenue growth of 5.38 %, achieved in the same quarter.
Sotera Health Company Net Income in the 2 quarter 2026 grew year on year by 573.74%, faster than the Sotera Health's competitors average income growth of 15.46 %
Sotera Health's Comment on Competition and Industry Peers
Nordion competes with companies based in Argentina, India, and Russia that primarily serve domestic markets with some exports to nearby countries. The Russian competitor has historically supplied China and Europe but currently faces export challenges due to geopolitical issues. Competitors in these regions may increase production capacity through significant capital investment. Nordion also encounters indirect competition from developing sterilization technologies, such as X-ray technology, which do not require cobalt-60 (Co-60) sources. In the high-specific-activity (HSA) Co-60 industry, Nordion's main competitors include suppliers in China, Sweden, and North America that produce medical Co-60 sources using cobalt sourced from various cobalt-producing countries. Other competitors mentioned in filings include Nelson Labs.
With revenue growth of 9.45 % within Overall company, Sotera Health Company achieved improvement in market share, within Overall company to approximately 15.81 %. << More on SHC Market Share.
*Market share is calculated based on total revenue.
Charles River Laboratories International inc Share Performance
-1.82%
30 Days
Charles River Laboratories International inc
Profile
Charles River Laboratories International Inc is a contract research organization (CRO) that provides essential services and support to the pharmaceutical, biotech, and medical device industries. They offer a wide range of research models, drug discovery and development services, safety assessments, and laboratory animal medicine to assist in the preclinical and clinical stages of drug development.
Labcorp Holdings Inc operates as a major healthcare diagnostics company, providing clinical laboratory tests and services to healthcare providers, pharmaceutical companies, and government agencies. Their business model emphasizes delivering accurate and timely test results to aid in patient diagnosis, treatment, and monitoring.
Medpace Holdings Inc is a contract research organization (CRO) that provides various services in the clinical research and development of drugs and medical devices.
Steris Plc operates in the healthcare industry by providing comprehensive infection prevention, decontamination, surgical, and critical care solutions designed for healthcare providers, including hospitals and pharmaceutical manufacturers. Their business model focuses on delivering a diverse array of innovative products, services, and software that enhance safety, efficiency, and overall patient outcomes in medical environments.
Sources:
Sotera Health Company’s official press releases and regulatory filings; CSIMarket.com’s market research; and the financial filings and press releases of other companies cited in this report.
Updated on:
Focus of this report: publicly traded companies.
For your research, we’ve provided 10 tables on Sotera Health Company versus competitors, including market share analysis.
You can find them in the navigation menu under Competition.
To download the tables, please subscribe.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.
